您当前的位置:
首页 >
文章列表页 >
Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review
更新时间:2022-11-02
    • Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 28, Issue 23, Pages: 237-249(2022)
    • DOI:10.13422/j.cnki.syfjx.20221308    

      CLC: R2-0;R22;R285.5;R284;R33
    • Received:31 March 2022

      Published Online:30 June 2022

      Published:05 December 2022

    移动端阅览

  • PAN Baochao,LI Hanzhou,ZHANG Hui,et al.Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(23):237-249. DOI: 10.13422/j.cnki.syfjx.20221308.

  •  
  •  

0

Views

22

下载量

5

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese Medicine Regulates NLRP3 Inflammasomes to Treat Diabetic Nephropathy: A Review
Chinese Medicine Regulates Atherosclerosis-related Signaling Pathway: A Review
Mechanism of Mitochondrial Autophagy and Intervention of Traditional Chinese Medicine in Renal Fibrosis: A Review
Clinical and Animal Experimental Research on Kidney Deficiency Syndrome: A Review

Related Author

ZHAO Zhe
BAI Min
JIN Yuqiu
TIAN Mengyuan
CHEN Guangshun
LIU Zhenhua
Manli ZHOU
Yanzhen ZHAO

Related Institution

Gansu University of Chinese Medicine
School of Traditional Chinese Medicine(TCM), Hunan University of Chinese Medicine
Hunan Provincial Key Laboratory of Diagnostics of TCM, Hunan University of Chinese Medicine
Nanjing University of Chinese Medicine
Changzhou Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine
0